NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM2309844 Query DataSets for GSM2309844
Status Public on Sep 13, 2016
Title 03-1-0026-1
Sample type SRA
 
Source name blood
Organism Homo sapiens
Characteristics time of blood draw: 1 week post-transplant
race: Caucasian / White
ethnicity: Non-Hispanic/Non-Latino
gender: M
primary disease: Nephritis,@2 other drugs
transplanted organ: Kidney
transplant type: kidney
age at transplant: 55.37
Treatment protocol Blood was collected into BD Vacutainer EDTA coated tubes. RNA was isolated from approximately 12 mLs of whole blood PBMCs using the Qiagen QIAamp RNA Blood Mini kit (Germantown, MD) within 2 hours of blood draw.
Growth protocol Adults receiving living donor kidney allografts were studied. Patients received thymoglobulin induction and maintenance therapy with tacrolimus or cyclosporine, with mycophenolate and short course steroids to days 5–7 post-transplant. Four of the patients received tacrolimus or cyclosporine prior to transplantation. Five patients were receiving steroids and 9 were receiving mycophenolate at baseline for underlying disease. The subjects had no rejection or any previous rejection at time of each sample collection. Sequential whole blood samples for isolation of PBMCs were collected at baseline (pre-transplant, n = 32), week 1 (n = 31), month 3 (n = 18) and month 6 (n = 15) post-transplant. Some samples were not obtained because patients did not return to the transplant clinic for follow-up center visits and clinical follow ups were performed by referring physician. All patients in this study provided written informed consent following protocol that was approved by the institutional review board of the University of Minnesota.
Extracted molecule total RNA
Extraction protocol Qiagen QIAamp RNA Blood Mini kit (Germantown, MD)
RNA was quantitated with a Nanodrop 800 spectrophotometer. One μg of each RNA sample was used to prepare RNAseq libraries based on the method as outlined by Zhong and colleagues [reference 17 in published manuscript] with modifications and added quality checks. Sample quantity and integrity was checked using RiboGreen analysis and an Agilent 2100 Bioanalyzer or Caliper equivalent. Each sample passing quality control (RNA mass > 1 μg and RNA Integrity Number > 6) was used to create a polyA+ stranded barcoded RNAseq library using standard protocols. Five samples were pooled for each lane for Illumina Hi-seq 2000 sequencing to generate 20–40 million mapped paired-end reads per sample.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2000
 
Data processing Illumina Native files converted to FASTQ by Minnesota Supercomputing Institute
FASTQ files assessed for quality by FastQC:Read QC
Paired-end reads aligned to human genome (GRCH37/hg19) via Tophat2 using iGenome UCSC reference annontation
Transcript assembly and abundance was determined using Cufflinks with hg_19_genes_2012-30-09.gtf reference annotation
Genome_build: GRCH37/hg19
 
Submission date Sep 13, 2016
Last update date May 15, 2019
Contact name Casey Dorr
E-mail(s) cdorr@mmrf.org
Organization name Minneapolis Medical Research Foundation
Street address 701 Park Avenue
City Minneapolis
State/province MN
ZIP/Postal code 55415
Country USA
 
Platform ID GPL11154
Series (1)
GSE86884 Differentially Expressed Gene Transcripts Using RNA Sequencing from the Blood of Immunosuppressed Kidney Allograft Recipients
Relations
Reanalyzed by GSE122515
BioSample SAMN05770098
SRA SRX2162322

Supplementary file Size Download File type/resource
GSM2309844_Cufflinks_on_03-1-0026-1_gene_expression.xlsx 3.3 Mb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap